Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2022-06-29 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Loss of share certificate
Share Issue/Capital Change Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the issuance of a duplicate share certificate. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is about informing the exchanges of a share certificate issuance, not about financial results, management changes, or other report types. The document length is short (1785 characters) and is an announcement of a corporate action related to shares. This fits the category of Share Issue/Capital Change (SHA), as it involves issuance of duplicate share certificates, a capital-related event.
2022-06-29 English
Intimation of Issue of Duplicate Share Certificate
Share Issue/Capital Change Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the issuance of a duplicate share certificate. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is about notifying the exchanges of a share certificate issuance, not about financial results, management changes, or other report types. The document length is short (1785 characters) and is an official notification rather than a report or detailed filing. This fits the category of Share Issue/Capital Change (SHA), as it concerns share certificate issuance and related capital documentation.
2022-06-29 English
Record Date
Share Issue/Capital Change Classification · 95% confidence The document is a short notice from Torrent Pharmaceuticals Limited addressed to the National Stock Exchange of India regarding the fixation of a Record Date for allotment of bonus equity shares. It references Regulation 42 of the SEBI Listing Regulations and mentions that approval is sought via Postal Ballot with results to be announced later. The document is brief (1778 characters) and serves as an announcement of a corporate action related to share capital (bonus shares). It does not contain financial statements or detailed financial data, nor is it a report or detailed presentation. It is an announcement about a capital change event (bonus share allotment) contingent on shareholder approval. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2022-06-29 English
Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Monday, 11th July, 2022 as the Record Date for the purpose of determining the names of Members who shall be entitled ....
Share Issue/Capital Change Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the intimation of a Record Date for allotment of bonus equity shares. It references Regulation 42 of the SEBI Listing Regulations, which pertains to the record date for shareholder entitlements. The document is short (1825 characters) and serves as an announcement of a corporate action (bonus share allotment) rather than a financial report or detailed filing. It does not contain financial statements, audit information, or management discussion. It is not a report itself but an official notification related to capital changes. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA).
2022-06-29 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the closure of the trading window for designated persons due to the upcoming financial results announcement for the quarter ended June 30, 2022. It references compliance with SEBI regulations and the company's internal code of conduct for trading by insiders. The document does not contain any financial data or results itself, nor does it present a report or detailed financial information. It is a regulatory announcement related to trading restrictions ahead of financial disclosures. Given the short length (1594 characters) and the nature of the content, this fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2022-06-29 English
Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the closure of the trading window for designated persons due to the upcoming financial results announcement for the quarter ended June 30, 2022. It references compliance with SEBI regulations and the company's internal code of conduct. The document does not contain any financial data, detailed report, or analysis. It is an announcement related to trading restrictions ahead of financial results, not the financial results or report itself. The document length is only 1594 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-06-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.